Business
Planning approved for bioscience development
Planning approved for bioscience development.
About this update from Conygar Investment Company Plc
[{"type":"text","content":"\n\n \n \n 18th May 2023\nTHE CONYGAR INVESTMENT COMPANY PLC\nPlanning approved for bioscience development\nat The Island Quarter, Nottingham\nThe Conygar Investment Company PLC (\"Conygar\") is pleased to announce that Nottingham City Council has approved its detailed application for the next phase of The Island Quarter development in Nottingham. The application comprises a 23,123 sq.m. (249,000 sq.ft.) bioscience building, which includes both laboratory and office space. The permission is subject to the documenting of the section 106 agreement.\nRobert Ware, Chief Executive of Conygar, commented:\n\"We are delighted that the next phase of development has been approved. Nottingham is already home to a large number of exciting businesses in the bioscience space and this scheme will be an excellent addition to the mixed-use development we are creating at The Island Quarter\".\nEnquiries:\nThe Conygar Investment Company PLC\nRobert Ware: 020 7258 8670 \nLiberum Capital Limited (Nominated Adviser and Broker)\nRichard Lindley: 020 3100 2185\nTemple Bar Advisory (Public Relations)\nAlex Child-Villiers: 07795 425580\nWilliam Barker: 07827 960151\n\n","length":2180,"tagName":"div"}]